Related Experiment Videos
Treating schizophrenia now and developing strategies for the next decade
1Department of Psychiatry, University of Michigan Medical Center, Ann Arbor, MI, USA.
CNS Spectrums
|August 18, 2004
Summary
Current schizophrenia (SZ) treatments, though serendipitous, are effective. Future drug development strategies focus on limbic cortex targets for improved antipsychotic therapies.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Schizophrenia (SZ) treatments currently rely on serendipitously discovered drugs.
- A wide range of effective pharmacologic options exist for individualized SZ therapy.
Purpose of the Study:
- To review current schizophrenia treatments and propose a strategy for rational antipsychotic drug development.
- To identify potential drug targets in the limbic cortex for future SZ research.
Main Methods:
- Review of pharmacologic characteristics of commonly prescribed antipsychotic medications.
- Presentation of a proposed strategy for rational antipsychotic drug discovery.
- Laboratory data illustrating the application of the proposed drug development strategy.
Main Results:
- A spectrum of effective antipsychotic drugs supports individualized patient therapy.
- Proposed strategy suggests targeting the anterior cingulate and/or hippocampal cortex.
- Data indicate the limbic cortex as a key area for SZ pathophysiology.
Conclusions:
- Current pharmacotherapies for schizophrenia are effective but lack a rational development basis.
- The proposed strategy offers a framework for developing novel antipsychotic medications.
- Future research focusing on limbic cortical targets holds promise for advancing schizophrenia treatment.